Petra Acquisition, Inc.
Status: Closed Deal
U=S+W
W=S@11.5
| IPO Proceeds, $M | $72.78M |
|---|---|
| IPO Date | Oct 8, 2020 |
| CEO | Andreas Typaldos |
| Left Lead | LifeSci Capital |
| IPO Cash in Trust | 101.3% |
| SPAC Tenor | 12+1+1+1 |
| IPO Sector | Healthcare ▶ |
| IPO Geography | Global |
| Target Company | Revelation Biosciences, Inc. |
| Deal Announced | Aug 30, 2021 |
| Deal Size, $M | $127.70M |
| Deal Sector | Healthcare |
| Deal Geography | US/Canada |
| SEC Filings |
www.sec.gov 
|
| Approval Vote | Jan 6, 2022 |
| Amendment Vote | TBD |
| Closing Date | Jan 10, 2022 |
Formerly PAIC
REVB
REVBW
| Price | $2.99 $0.00 |
|---|---|
| Last closing price | $2.86 |
| H/L, today | $2.80 / $3.11 |
| H/L, 52-week | $0.56 / $11.39 |
| Volume, today | 60,644 |
| Volume, 3-month avg. | N/A |
Sign up for Free Trial
No credit card required
Sign in to view structure, cap table, and calendar of events.